Article Sidebar

PDF
Date Published: 13/03/2022
Abstract Views: 226
Views PDF: 389
DOI: https://doi.org/10.51298/vmj.v510i2.2016
Issue
Vol. 510 No. 2 (2022)
Section
Các bài báo
How to Cite
Thị Thu Phương, N., & Thị Quỳnh Mai, N. . (2022). SURVEY ON SUBCLINICAL CHARACTERISTICS OF PATIENTS WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AT HAI PHONG INTERNATIONAL GENERAL HOSPITAL. Vietnam Medical Journal, 510(2). https://doi.org/10.51298/vmj.v510i2.2016

SURVEY ON SUBCLINICAL CHARACTERISTICS OF PATIENTS WITH GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY AT HAI PHONG INTERNATIONAL GENERAL HOSPITAL

Nguyễn Thị Thu Phương1,2,, Ngô Thị Quỳnh Mai3
1 Haiphong University of Medicine and Pharmacy
2 Hai Phong International General Hospital
3 Trường Đại học Y Dược Hải Phòng

Main Article Content

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme defect in humans and one of the most common genetic disorders worldwide. lifespan of red blood cells. Therefore, we carried out this study with the aim of investigating anemia in chronic G6PD deficiency patients treated at Hai Phong International General Hospital in 2020. From there, we analyzed the factors. affects the occurrence of anemia in the study group of patients Our study has retrospectively reviewed the medical records of 46 patients diagnosed with G6PD enzyme deficiency. Our study showed that 65,2% of patients were male. The average concentration of G6PD enzyme at the time of detection was 2,4±2,4 (U/g). The average hematocrit concentration of the study group was 0,38±0,06. The average hematocrit concentration of the study group was 0,38±0,06. This result contributes to supporting clinicians in the prognostication and monitoring of patients with G6PD deficiency to improve treatment efficacy.

Article Details

Keywords

G6PD deficiency, anemia

References

1. Youngster, I., et al., Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf, 2010. 33(9): p. 713-726.
2. Sklar, G.E., Hemolysis as a potential complication of acetaminophen overdose in a patient with glucose-6-phosphate dehydrogenase deficiency. Pharmacotherapy, 2002. 22(5): p. 656-658.
3. Gandapur, A.S., et al., Frequency of glucose 6 phosphate dehydrogenase deficiency and related hemolytic anemia in Riyadh, Saudi Arabia. J Ayub Med Coll Abbottabad, 2002. 14(3): p. 24-6.
4. Howes, R.E., et al., G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med, 2012. 9(11): p. e1001339.
5. Hagag, A.A., et al., Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study. Endocr Metab Immune Disord Drug Targets, 2018. 18(2): p. 155-162.
6. Gomez-Manzo, S., et al., The stability of G6PD is affected by mutations with different clinical phenotypes. Int J Mol Sci, 2014. 15(11): p. 21179-21201.
7. Pes, G.M., G. Parodi, and M.P. Dore, Glucose-6-phosphate dehydrogenase deficiency and risk of cardiovascular disease: A propensity score-matched study. Atherosclerosis, 2019. 282: p. 148-153.
8. Benchimol, M., L.B. Madeira, and R. de Oliveira-Souza, Late-Life Presentation of Unsuspected G6PD Deficiency. Case Rep Crit Care, 2018. 2018: p. 8198565.